Autism Spectrum Disorder
Conditions
Interventions
Experimental group: 30 children with autism spectrum disorder will receive cannabidiol-rich cannabis extract. Control group: 30 children with autism spectrum disorder will receive a placebo. The sampl
56096
Sponsors
Universidade Federal da Paraíba
Eligibility
Age
5 Years to 12 Years
Inclusion criteria
Inclusion criteria: Children aged 5 to 12 years old; live in Paraíba, Pernambuco or Rio Grande do Norte, Brazil; diagnosed with Autism Spectrum Disorder; registered on the site.
Exclusion criteria
Exclusion criteria: Diabetes mellitus; systemic arterial hypertension; autoimmune diseases; refractory epilepsy; who have used any cannabis-based product in the past two months; are under five or over 12 years old.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To evaluate the efficacy of cannabidiol-rich cannabis extract in the symptoms of autism spectrum disorder: social interaction, language and stereotyped movements;CBD-rich cannabis extract was effective for social interaction (p<0.001) | — |
Secondary
| Measure | Time frame |
|---|---|
| To evaluate the efficacy of cannabidiol-rich cannabis extract in the coexisting syntoms of autism spectrum disorder (aggressiveness, psychomotor agitation, concentration, eating habits, sleep and anxiety);CBD-rich cannabis extract was effective for psychomotor agitation (p<0.01), eating habits (p<0.05), anxiety (p<0.01), and concentration only in mild-grade children (p<0.01). | — |
Countries
Brazil
Contacts
Public ContactEstácio Silva Junior
Universidade Federal da Paraíba
Outcome results
None listed